Skip to main content
OpenTrials
Completed

NCT Number: NCT00908973

Gut Hormone Response, Appetite and Intestinal Transit Time in Good and Poor Weight Responders After Gastric Bypass

The aim of the study is to describe differences in meal-stimulated gut hormone response, appetite and intestinal transit time between good and poor responders 1-2 years after Gastric Bypass surgery for obesity.

Completed

Looking for future studies?

Notify Me

Key information

Age range

20 year–60 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Department of Endocrinology at Hvidovre University Hospital

Hvidovre, Copenhagen, DK-2650, Denmark

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 20-60 years
  • Completed laparoscopic gastric bypass surgery without complications (cases)
  • No previous gastric bypass surgery (controls)

Exclusion criteria

  • Diabetes
  • Disease or treatment interfering with appetite or gastrointestinal motility
  • Pregnancy or breastfeeding
  • Excess weight loss 1 year after gastric bypass > 50% and =< 60% (cases)

Sponsors and collaborators

Lead sponsor

Hvidovre University Hospital

Other

Collaborators

  • Novo Nordisk A/S
  • University of Copenhagen

Registry information

Official study title

Gut Hormone Response, Appetite and Intestinal Transit Time in Good and Poor Weight Responders 1-2 Years After Gastric Bypass

Acronym: RnonR

Important dates

Study start
2009
Primary completion
2011
Study completion
2011
First posted
May 27, 2009
Registry last updated
Mar 20, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.